NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE46509 Query DataSets for GSE46509
Status Public on May 01, 2013
Title Molecular profile of parvalbumin-immunoreactive neurons in superior temporal cortex in schizophrenia
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann’s area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. 739 mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH and PGE2 (prostaglandin E2) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons as found in the accompanying study, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type-specific. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of targeted molecular intervention.
 
Overall design Gene expression microarray from mRNA isolated from parvalbumin cells in layer 3 of the STG from 8 normal controls and 8 subjects with schizophrenia. There was no significant difference between diagnosis groups for age, sex, and post mortem interval (PMI).
 
Contributor(s) Pietersen CY, Mauney SA, Kim SS, Passeri E, Lim MP, Goldstein JM, Petreyshen TL, Seidman LJ, Shenton ME, McCarley RW, Sonntag K, Woo TW
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 30, 2013
Last update date May 02, 2013
Contact name Sarah Mauney
E-mail(s) smauney@mclean.harvard.edu
Phone 6178552079
Fax 6178553479
Organization name McLean Hospital
Lab Laboratory for Cellular Neuropathology
Street address 115 Mill St.
City Belmont
State/province MA
ZIP/Postal code 02478
Country USA
 
Platforms (1)
GPL1352 [U133_X3P] Affymetrix Human X3P Array
Samples (16)
GSM1131352 Brain_Control_Subject1
GSM1131353 Brain_Control_Subject2
GSM1131354 Brain_Control_Subject4
Relations
BioProject PRJNA200703

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE46509_RAW.tar 74.3 Mb (http)(custom) TAR (of CEL, CHP)
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap